HEADER HYDROLASE 26-JAN-22 7WQX TITLE STRUCTURE OF INACTIVE-EP COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENTEROPEPTIDASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ENTEROKINASE,SERINE PROTEASE 7,TRANSMEMBRANE PROTEASE SERINE COMPND 5 15; COMPND 6 EC: 3.4.21.9; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TMPRSS15, ENTK, PRSS7; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS COMPLEX, MEMBRANE PROTEIN, HYDROLASE EXPDTA ELECTRON MICROSCOPY AUTHOR X.L.YANG,Z.Y.DING,H.J.HUANG REVDAT 2 23-NOV-22 7WQX 1 JRNL REVDAT 1 26-OCT-22 7WQX 0 JRNL AUTH X.YANG,Z.DING,L.PENG,Q.SONG,D.ZHANG,F.CUI,C.XIA,K.LI,H.YIN, JRNL AUTH 2 S.LI,Z.LI,H.HUANG JRNL TITL CRYO-EM STRUCTURES REVEAL THE ACTIVATION AND SUBSTRATE JRNL TITL 2 RECOGNITION MECHANISM OF HUMAN ENTEROPEPTIDASE. JRNL REF NAT COMMUN V. 13 6955 2022 JRNL REFN ESSN 2041-1723 JRNL PMID 36376282 JRNL DOI 10.1038/S41467-022-34364-9 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.700 REMARK 3 NUMBER OF PARTICLES : 511658 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7WQX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 02-FEB-22. REMARK 100 THE DEPOSITION ID IS D_1300027281. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : INACTIVE-EP REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.60 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 SUMMIT (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 700.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 3400.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5200.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 584 OG1 THR A 609 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 543 43.25 -80.44 REMARK 500 ASN A 575 -163.95 -77.80 REMARK 500 GLU A 586 -0.73 67.39 REMARK 500 GLU A 587 -166.67 -160.60 REMARK 500 CYS A 643 -167.28 -79.58 REMARK 500 ILE A 730 -63.13 -121.03 REMARK 500 GLN A 756 115.91 -162.99 REMARK 500 GLN A 759 56.40 37.89 REMARK 500 LYS A 770 -167.58 -79.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-32715 RELATED DB: EMDB REMARK 900 INACTIVE-EP DBREF 7WQX A 519 1019 UNP P98073 ENTK_HUMAN 519 1019 SEQRES 1 A 501 GLU LEU PRO THR ASP CYS GLY GLY PRO PHE GLU LEU TRP SEQRES 2 A 501 GLU PRO ASN THR THR PHE SER SER THR ASN PHE PRO ASN SEQRES 3 A 501 SER TYR PRO ASN LEU ALA PHE CYS VAL TRP ILE LEU ASN SEQRES 4 A 501 ALA GLN LYS GLY LYS ASN ILE GLN LEU HIS PHE GLN GLU SEQRES 5 A 501 PHE ASP LEU GLU ASN ILE ASN ASP VAL VAL GLU ILE ARG SEQRES 6 A 501 ASP GLY GLU GLU ALA ASP SER LEU LEU LEU ALA VAL TYR SEQRES 7 A 501 THR GLY PRO GLY PRO VAL LYS ASP VAL PHE SER THR THR SEQRES 8 A 501 ASN ARG MET THR VAL LEU LEU ILE THR ASN ASP VAL LEU SEQRES 9 A 501 ALA ARG GLY GLY PHE LYS ALA ASN PHE THR THR GLY TYR SEQRES 10 A 501 HIS LEU GLY ILE PRO GLU PRO CYS LYS ALA ASP HIS PHE SEQRES 11 A 501 GLN CYS LYS ASN GLY GLU CYS VAL PRO LEU VAL ASN LEU SEQRES 12 A 501 CYS ASP GLY HIS LEU HIS CYS GLU ASP GLY SER ASP GLU SEQRES 13 A 501 ALA ASP CYS VAL ARG PHE PHE ASN GLY THR THR ASN ASN SEQRES 14 A 501 ASN GLY LEU VAL ARG PHE ARG ILE GLN SER ILE TRP HIS SEQRES 15 A 501 THR ALA CYS ALA GLU ASN TRP THR THR GLN ILE SER ASN SEQRES 16 A 501 ASP VAL CYS GLN LEU LEU GLY LEU GLY SER GLY ASN SER SEQRES 17 A 501 SER LYS PRO ILE PHE PRO THR ASP GLY GLY PRO PHE VAL SEQRES 18 A 501 LYS LEU ASN THR ALA PRO ASP GLY HIS LEU ILE LEU THR SEQRES 19 A 501 PRO SER GLN GLN CYS LEU GLN ASP SER LEU ILE ARG LEU SEQRES 20 A 501 GLN CYS ASN HIS LYS SER CYS GLY LYS LYS LEU ALA ALA SEQRES 21 A 501 GLN ASP ILE THR PRO LYS ILE VAL GLY GLY SER ASN ALA SEQRES 22 A 501 LYS GLU GLY ALA TRP PRO TRP VAL VAL GLY LEU TYR TYR SEQRES 23 A 501 GLY GLY ARG LEU LEU CYS GLY ALA SER LEU VAL SER SER SEQRES 24 A 501 ASP TRP LEU VAL SER ALA ALA HIS CYS VAL TYR GLY ARG SEQRES 25 A 501 ASN LEU GLU PRO SER LYS TRP THR ALA ILE LEU GLY LEU SEQRES 26 A 501 HIS MET LYS SER ASN LEU THR SER PRO GLN THR VAL PRO SEQRES 27 A 501 ARG LEU ILE ASP GLU ILE VAL ILE ASN PRO HIS TYR ASN SEQRES 28 A 501 ARG ARG ARG LYS ASP ASN ASP ILE ALA MET MET HIS LEU SEQRES 29 A 501 GLU PHE LYS VAL ASN TYR THR ASP TYR ILE GLN PRO ILE SEQRES 30 A 501 CYS LEU PRO GLU GLU ASN GLN VAL PHE PRO PRO GLY ARG SEQRES 31 A 501 ASN CYS SER ILE ALA GLY TRP GLY THR VAL VAL TYR GLN SEQRES 32 A 501 GLY THR THR ALA ASN ILE LEU GLN GLU ALA ASP VAL PRO SEQRES 33 A 501 LEU LEU SER ASN GLU ARG CYS GLN GLN GLN MET PRO GLU SEQRES 34 A 501 TYR ASN ILE THR GLU ASN MET ILE CYS ALA GLY TYR GLU SEQRES 35 A 501 GLU GLY GLY ILE ASP SER CYS GLN GLY ASP SER GLY GLY SEQRES 36 A 501 PRO LEU MET CYS GLN GLU ASN ASN ARG TRP PHE LEU ALA SEQRES 37 A 501 GLY VAL THR SER PHE GLY TYR LYS CYS ALA LEU PRO ASN SEQRES 38 A 501 ARG PRO GLY VAL TYR ALA ARG VAL SER ARG PHE THR GLU SEQRES 39 A 501 TRP ILE GLN SER PHE LEU HIS HET NAG A1101 14 HET NAG A1102 14 HET NAG A1103 14 HET NAG A1104 14 HET NAG A1105 14 HET NAG A1106 14 HET NAG A1107 14 HET NAG A1108 14 HET NAG A1109 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG 9(C8 H15 N O6) HELIX 1 AA1 VAL A 659 LEU A 661 5 3 HELIX 2 AA2 ILE A 711 LEU A 719 1 9 HELIX 3 AA3 GLU A 833 SER A 835 5 3 HELIX 4 AA4 SER A 937 MET A 945 1 9 HELIX 5 AA5 VAL A 1007 ARG A 1009 5 3 HELIX 6 AA6 PHE A 1010 HIS A 1019 1 10 SHEET 1 AA1 4 GLU A 529 LEU A 530 0 SHEET 2 AA1 4 ILE A 555 ASN A 557 1 O ILE A 555 N LEU A 530 SHEET 3 AA1 4 ARG A 611 ILE A 617 -1 O MET A 612 N LEU A 556 SHEET 4 AA1 4 PHE A 551 VAL A 553 -1 N CYS A 552 O LEU A 616 SHEET 1 AA2 5 GLU A 529 LEU A 530 0 SHEET 2 AA2 5 ILE A 555 ASN A 557 1 O ILE A 555 N LEU A 530 SHEET 3 AA2 5 ARG A 611 ILE A 617 -1 O MET A 612 N LEU A 556 SHEET 4 AA2 5 VAL A 579 ARG A 583 -1 N GLU A 581 O LEU A 615 SHEET 5 AA2 5 ALA A 594 TYR A 596 -1 O ALA A 594 N ILE A 582 SHEET 1 AA3 4 THR A 536 SER A 538 0 SHEET 2 AA3 4 GLY A 626 GLY A 634 -1 O ALA A 629 N PHE A 537 SHEET 3 AA3 4 ASN A 563 ASP A 572 -1 N ASN A 563 O GLY A 634 SHEET 4 AA3 4 VAL A 605 PHE A 606 -1 O VAL A 605 N LEU A 566 SHEET 1 AA4 2 HIS A 647 GLN A 649 0 SHEET 2 AA4 2 CYS A 655 PRO A 657 -1 O VAL A 656 N PHE A 648 SHEET 1 AA5 3 ASN A 688 GLY A 689 0 SHEET 2 AA5 3 LEU A 765 CYS A 767 -1 O LEU A 765 N GLY A 689 SHEET 3 AA5 3 GLY A 724 SER A 727 -1 N ASN A 725 O GLN A 766 SHEET 1 AA6 2 PHE A 693 ILE A 695 0 SHEET 2 AA6 2 ILE A 698 HIS A 700 -1 O ILE A 698 N ILE A 695 SHEET 1 AA7 2 LYS A 740 ASN A 742 0 SHEET 2 AA7 2 ILE A 750 THR A 752 -1 O THR A 752 N LYS A 740 SHEET 1 AA8 7 VAL A 799 TYR A 804 0 SHEET 2 AA8 7 ALA A 812 LEU A 814 -1 O ALA A 812 N VAL A 800 SHEET 3 AA8 7 TRP A 819 SER A 822 -1 O VAL A 821 N SER A 813 SHEET 4 AA8 7 ALA A 878 LEU A 882 -1 O ALA A 878 N SER A 822 SHEET 5 AA8 7 VAL A 855 ILE A 864 -1 N VAL A 863 O MET A 879 SHEET 6 AA8 7 TRP A 837 LEU A 841 -1 N LEU A 841 O VAL A 855 SHEET 7 AA8 7 VAL A 799 TYR A 804 -1 N TYR A 803 O THR A 838 SHEET 1 AA9 5 ASN A 909 GLY A 914 0 SHEET 2 AA9 5 GLN A 929 LEU A 936 -1 O VAL A 933 N CYS A 910 SHEET 3 AA9 5 MET A 954 ALA A 957 -1 O CYS A 956 N LEU A 936 SHEET 4 AA9 5 GLY A1002 ALA A1005 -1 O TYR A1004 N ILE A 955 SHEET 5 AA9 5 VAL A 988 PHE A 991 -1 N VAL A 988 O ALA A1005 SSBOND 1 CYS A 643 CYS A 655 1555 1555 2.03 SSBOND 2 CYS A 650 CYS A 668 1555 1555 2.03 SSBOND 3 CYS A 662 CYS A 677 1555 1555 2.03 SSBOND 4 CYS A 716 CYS A 767 1555 1555 2.03 SSBOND 5 CYS A 772 CYS A 896 1555 1555 2.03 SSBOND 6 CYS A 810 CYS A 826 1555 1555 2.03 SSBOND 7 CYS A 910 CYS A 977 1555 1555 2.03 SSBOND 8 CYS A 941 CYS A 956 1555 1555 2.03 SSBOND 9 CYS A 967 CYS A 995 1555 1555 2.03 LINK ND2 ASN A 534 C1 NAG A1102 1555 1555 1.44 LINK ND2 ASN A 630 C1 NAG A1103 1555 1555 1.44 LINK ND2 ASN A 682 C1 NAG A1104 1555 1555 1.44 LINK ND2 ASN A 706 C1 NAG A1105 1555 1555 1.44 LINK ND2 ASN A 725 C1 NAG A1109 1555 1555 1.44 LINK ND2 ASN A 848 C1 NAG A1106 1555 1555 1.44 LINK ND2 ASN A 887 C1 NAG A1107 1555 1555 1.44 LINK ND2 ASN A 909 C1 NAG A1101 1555 1555 1.44 LINK ND2 ASN A 949 C1 NAG A1108 1555 1555 1.44 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000